Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: Looking at Treatment Regimens for HR+ Breast Cancer and Triple-Negative Breast Cancer, March 2023

Author:

Yara Abdou, MD

• Read More

Clinical Edge Journal Scan

Ethylene oxide emissions increase risk for ductal carcinoma in situ of the breast

• Read More

Clinical Edge Journal Scan

Meta-analysis shows link between pretreatment prognostic nutritional index and survival in breast cancer

• Read More

Clinical Edge Journal Scan

Interval BC have more unfavorable characteristics than screen-detected BC

• Read More

Clinical Edge Journal Scan

Risk for local recurrence higher in microinvasive vs T1a-2 BC

• Read More

Clinical Edge Journal Scan

High PD-L2 levels may predict worse clinical outcomes in ER+ BC

• Read More

Clinical Edge Journal Scan

Adjuvant abemaciclib+ET shows treatment benefit regardless of menopausal status in HR+/HER2− early BC

• Read More

Clinical Edge Journal Scan

Adding ET to dual anti-HER2 targeted therapy beneficial in HER2+/HR+ metastatic BC

• Read More

Clinical Edge Journal Scan

SPIO can help avoid upfront sentinel lymph node dissection in ductal carcinoma in situ of the breast

• Read More

Clinical Edge Journal Scan

Contralateral prophylactic mastectomy offers no survival advantage in TNBC

• Read More